Skip to main content
    B

    Bio-Techne Corp (TECH)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $72.63
    -0.16 (-0.22%)

    Market Cap: $11.43B

    Last updated: Nov 17, 2026 at 4:34 PM ET

    Bio-Techne Corp (TECH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Bio-Techne (TECH) has a market cap of $11.43B and an enterprise value of $11.28B. Its trailing P/E is 39.5x.

    Total Valuation

    Enterprise value is 1.31% below the market cap, as cash exceeds debt.

    Market Cap$11.43B
    Enterprise Value$11.28B
    Latest price (Nov 17, 2026)$72.63

    Key Dates

    The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 13, 2026.

    Next Earnings DateFeb 2, 2027 (expected)
    Last Earnings DateNov 3, 2026
    Last Ex-Dividend DateNov 13, 2026
    Next Payment DateNov 23, 2026
    Fiscal Year EndJune

    Share Statistics

    The share count shrank 0.28% a year over 3 years.

    Shares Outstanding156.80M
    Shares Change (YoY)+0.86%
    Share Count Growth (3Y CAGR)-0.28%

    Valuation Ratios

    Sales and book value multiples are 9.3x and 5.3x. Its year-end P/E ranged from 28.9x to 69.9x from 2016 to 2025.

    P/E Ratio39.5x
    Forward P/E35.0x
    P/S Ratio9.3x
    Forward P/S8.9x
    P/B Ratio5.3x
    P/TBV Ratio12.6x
    P/FCF Ratio37.0x
    P/OCF Ratio33.9x
    PEG Ratio4.6

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 33.3x EBITDA and 36.5x free cash flow.

    EV / Earnings65.6x
    EV / Sales9.2x
    EV / EBITDA33.3x
    EV / EBIT46.9x
    EV / FCF36.5x

    Price Statistics

    The stock is up 22.64% over 52 weeks and trades 0.22% above its 50-day average.

    Beta (1Y)0.61
    52-Week Change+22.64%
    1-Month Change+0.30%
    3-Month Change+0.43%
    6-Month Change+59.91%
    5-Year Change-44.50%
    10-Year Change+179.49%
    Total Return (1Y)+23.18%
    Total Return (3Y CAGR)+6.31%
    Total Return (5Y CAGR)-9.80%
    Return vs SPY (1Y)+13.51%
    Max Drawdown (1Y)-39.32%
    Max Drawdown (3Y)-48.30%
    Sharpe Ratio (1Y)0.53
    Correlation with SPY (1Y)0.20
    50-Day Average$72.47
    200-Day Average$63.35
    52-Week Range$42.98 to $72.85
    RSI (14 Days)52.2
    Average Volume (20 Days)3.17M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.28x current liabilities, and total debt is 0.09x shareholder equity.

    Current Ratio2.28x
    Quick Ratio1.74x
    Debt / Equity0.09x
    Debt / EBITDA0.59x
    Debt / FCF0.65x
    Interest Coverage25.55x

    Returns and Efficiency

    Return on invested capital is 7.70% over the last 12 months, against a 5-year average of 9.09%.

    Return on Equity (ROE)7.94%
    Return on Assets (ROA)6.52%
    Return on Invested Capital (ROIC)7.70%
    Return on Capital Employed (ROCE)10.58%
    ROE (5Y Average)10.11%
    ROA (5Y Average)7.68%
    ROIC (5Y Average)9.09%
    Asset Turnover0.48x
    Inventory Turnover2.14x
    Receivables Turnover5.85x
    Cash Conversion Cycle208 days

    Taxes

    Income tax took 24.37% of pretax income over the last 12 months.

    Income Tax (TTM)$55.41M
    Effective Tax Rate24.37%

    Scores

    TECH has an Altman Z-Score of 16.09, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score16.09
    Altman Z ZoneSafe
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $1.23B over the last 12 months is up 0.94% from the 12 months before.

    Revenue$1.23B
    Revenue Growth (YoY)+0.94%
    Gross Profit$807.58M
    Operating Income$240.84M
    Pretax Income$227.38M
    Net Income$171.97M
    EBITDA$337.58M
    EBIT$240.84M
    Reported EPS (TTM)$1.84

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 82.20% of the $2.64B in total assets.

    Cash and Equivalents$350.04M
    Total Debt$200.00M
    Net Cash$150.04M
    Net Cash Per Share$0.96
    Working Capital$463.56M
    Shareholder Equity$2.17B
    Book Value Per Share$13.81
    Tangible Book Value$906.58M
    Tangible Book Per Share$5.78
    Total Assets$2.64B
    Total Liabilities$471.13M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $29.40M of capital spending, operating cash flow left $308.20M of free cash flow.

    Operating Cash Flow$337.60M
    Capital Expenditures$29.40M
    Free Cash Flow$308.20M
    FCF Per Share$1.96
    Depreciation and Amortization$96.75M
    Dividends Paid$50.03M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 19.61%, against a 5-year average of 20.01%.

    Gross Margin65.75%
    Operating Margin19.61%
    Pretax Margin18.51%
    Net Margin14.00%
    EBITDA Margin27.49%
    EBIT Margin19.61%
    FCF Margin25.09%
    Gross Margin (5Y Average)66.62%
    Operating Margin (5Y Average)20.01%
    Net Margin (5Y Average)16.88%

    Growth

    Revenue grew 2.25% a year over 3 years, and EPS fell 2.74% a year.

    Revenue Growth (3Y CAGR)+2.25%
    Revenue Growth (5Y CAGR)+5.47%
    EPS Growth (3Y CAGR)-2.74%
    EPS Growth (5Y CAGR)+1.72%
    FCF Growth (3Y CAGR)+6.79%
    FCF Growth (5Y CAGR)-3.08%
    Operating Income Growth (3Y CAGR)-5.55%

    Revenue and profit by year

    Dividends and Yields

    TECH pays out 14.86% of earnings as dividends.

    Dividend Per Share (Annual)$0.32
    Dividend Yield0.44%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)0.00%
    Dividend Growth (5Y CAGR)0.00%
    Payout Ratio14.86%
    FCF Payout Ratio16.23%
    Earnings Yield2.53%
    FCF Yield2.71%
    Buyback Yield0.37%
    Shareholder Yield0.80%

    Full dividend history

    Stock Splits

    The last split was a 4-for-1 forward split on Nov 30, 2022.

    Last Split DateNov 30, 2022
    Split TypeForward split
    Split Ratio4:1

    Peer Position

    Against 5 similar companies, TECH has the 4th highest P/E and the 3rd highest ROIC.

    P/E Ratio39.5x vs 40.4x median
    P/S Ratio9.3x vs 15.1x median
    ROIC7.70% vs -33.00% median
    Revenue Growth (Trailing 4 Quarters, YoY)+0.94% vs +37.28% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 7.21% and EPS growth at 12.10% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+7.21%
    EPS Growth Forecast (2Y CAGR)+12.10%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About TECH

    What is TECH's market cap?

    Bio-Techne has a market cap of $11.43B. Its enterprise value, which adds debt and subtracts cash, is $11.28B.

    What is TECH's P/E ratio?

    Bio-Techne has a trailing P/E ratio of 39.5x and a forward P/E of 35.0x.

    How many shares of TECH are outstanding?

    Bio-Techne has 156.80M shares outstanding. The count is up 0.86% from a year earlier.

    Does TECH pay a dividend?

    Yes. Bio-Techne pays $0.32 a share a year, a dividend yield of 0.44%.

    How much debt does TECH have?

    Bio-Techne has $200.00M of total debt and $350.04M of cash and equivalents, a net cash position of $150.04M.